Ultra-low price of generic agents in China may weaken patients' drug recognition and compliance-Reference-Cited by-同舟云学术

Ultra-low price of generic agents in China may weaken patients' drug recognition and compliance

Published:2020-04-30 Issue:2 Volume:14 Page:103-104
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Lu Saihua¹,Cai Jian²,Xu Feng¹

Affiliation:

1. Department of Clinical Pharmacy, Fengxian Hospital, Southern Medical University, Shanghai, China.

2. Department of Hospital Office, Fengxian Mental Health Center, Shanghai, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.01011/_pdf

Reference6 articles.

1. 1. Tang M, He JJ, Chen MX, Cong LX, Xu Y, Yang Y, Hou ZY, Song PP, Jin CL. "4+7" city drug volume-based purchasing and using pilot program in China and its impact. Drug Discov Ther. 2019; 13:365-369.

2. 2. Tang M, Song PP, He JJ. Progress on drug pricing negotiations in China. Biosci Trends. 2019; 13:464-468.

3. 3. Cai J, Ye M, Fei C, Xu F. Impact of brand-name drug worship and expectation psychology on antidepressant efficacy. Int J Clin Exp Med. 2013; 6:724-726.

4. 4. Li M, Cai J, Zhang P, Fei C, Xu F. Drug brand response and its impact on compliance and efficacy in depression patients. Front Pharmacol. 2017; 7:540.

5. 5. Hodgson GM. Darwin, Veblen and the problem of causality in economics. Hist Philos Life Sci. 2001; 23:385-423.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An empirical study of the impact of generic drug competition on drug market prices in China;Frontiers in Public Health;2023-05-25